Keyphrases
Xenograft Model
100%
Oligodendroglioma
100%
Mitochondrial Function
100%
IDH mutation
100%
2-Hydroxyglutarate (2-HG)
100%
In Situ Detection
100%
IDH1-R132H
100%
Isocitrate Dehydrogenase 1 (IDH1)
80%
Xenograft
60%
NADP+
40%
Tumor
20%
Cancer Cells
20%
Tumor Development
20%
Novel Therapeutics
20%
Patient-derived
20%
Tumorigenesis
20%
Tumor Cells
20%
In Situ
20%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
20%
Brain Parenchyma
20%
Mitochondria
20%
Tumor Metabolism
20%
Histologic
20%
Tumor Model
20%
Glioma
20%
High Density
20%
Point mutation
20%
Enzymatic Conversion
20%
Gliomagenesis
20%
Large Subgroup
20%
α-ketoglutarate (α-KG)
20%
Oncometabolite
20%
Secondary Glioblastoma
20%
Low-grade Diffuse Glioma
20%
Metabolic Level
20%
Mass Spectrometry Imaging
20%
Nanospray Desorption Electrospray Ionization (nano-DESI)
20%
Rational Development
20%
Fourier Transform Ion Cyclotron Resonance Mass Spectrometry (FT-ICR MS)
20%
Medicine and Dentistry
Xenograft
100%
Oligodendroglioma
100%
Neoplasm
40%
Ganglioglioma
40%
Nicotinamide Adenine Dinucleotide Phosphate
40%
Cancer Cell
20%
Carcinogenesis
20%
Tumor Cell
20%
Glioblastoma
20%
Parenchyma
20%
Tumor Model
20%
Point Mutation
20%
Mitochondrion
20%
Isocitrate Dehydrogenase
20%
Liquid Chromatography-Mass Spectrometry
20%
Electrospray Ionization
20%
Tumor Metabolism
20%
2 Hydroxyglutaric Acid
20%
Neuroscience
Oligodendroglioma
100%
Nicotinamide Adenine Dinucleotide Phosphate
66%
In Vivo
33%
Carcinogenesis
33%
Parenchyma
33%
Metabolic Pathway
33%
Point Mutation
33%
Isocitrate Dehydrogenase
33%
Liquid Chromatography-Mass Spectrometry
33%
Mitochondrion
33%
Biochemistry, Genetics and Molecular Biology
IDH1
100%
Nicotinamide Adenine Dinucleotide Phosphate
20%
Genetics
10%
Carcinogenesis
10%
Cancer Cell
10%
Metabolic Pathway
10%
Mitochondrion
10%
Point Mutation
10%
Liquid Chromatography-Mass Spectrometry
10%
Isocitrate Dehydrogenase
10%
Electrospray Ionization
10%